ZOETIS INC. CLASS A news, videos and press releases - Page 3
For more news please use our advanced search feature.
ZOETIS INC. CLASS A - More news...
ZOETIS INC. CLASS A - More news...
- Zoetis Named One of Most Innovative Companies in 2022 by Fast Company
- Zoetis Recognized as a Best Place To Work certification in Egypt for 2022
- Zoetis to Participate in the Bank of America Securities 2022 Animal Health Summit
- Zoetis Reports Fourth Quarter and Full Year 2021 Results
- Zoetis Declares Second Quarter 2022 Dividend
- Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats
- Zoetis Announces Expanded Commitments to Protect the Planet
- Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference
- Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
- Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program
- Zoetis Named One of Newsweek’s Most Responsible Companies for 2022
- Zoetis Announces Third Quarter 2021 Results
- Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
- Zoetis Declares Fourth Quarter 2021 Dividend
- Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
- Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
- Zoetis to Participate in the Jefferies Virtual Pet Care Summit
- Zoetis Announces Second Quarter 2021 Results
- Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock and Companion Animal Products
- Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2019 Financial Results
- Zoetis to Participate in the 38th Annual J.P. Morgan Healthcare Conference
- Zoetis Declares First Quarter 2020 Dividend; Board Approves 22% Payment Increase
- Zoetis Declares Fourth Quarter 2019 Dividend
- Zoetis Names Kristin Peck to Succeed Juan Ramón Alaix as CEO on January 1, 2020
- Zoetis to Host Webcast and Conference Call on Third Quarter 2019 Financial Results
- Zoetis Named a Top Company for Working Mothers
- European Commission Grants Marketing Authorisation to Simparica Trio™, a Once-Monthly Triple Combination Antiparasitic Medication for Dogs
- Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting
- Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2019 Dividend
- Forbes Names Zoetis One of America’s Best Employers for Fourth Year in a Row